Background. Subacute sclerosing panencephalitis (SSPE) is a fatal complication of measles. We reviewed California cases from 1998-2015 to understand risk factors for SPPE and estimate incidence.
Subacute sclerosing panencephalitis (SSPE) is a rare, fatal complication of measles characterized by cognitive and motor deterioration, with death typically occurring within 1-3 years of symptom onset [1] .
Prior to measles vaccination programs, the incidence of SSPE in developed countries was estimated at 1 case per 100 000 population, but was 100 times higher in some developing nations, suggesting that environmental or genetic factors or specific measles genotypes might be risk factors. A consistent SSPE risk factor has been measles infection before the second birthday [1] .
Measles vaccine prevents measles infection, thereby preventing SSPE. Vaccine-strain measles virus has not been demonstrated in SSPE [2] . Following implementation of effective measles vaccination programs, the incidence of SSPE decreased markedly [3, 4] . Studies suggest that the risk of SSPE is higher among persons infected with measles at a young age. During the 1989-1991 measles resurgence in the United States, SSPE risk was calculated as 1:4635; however, due to likely underreporting of measles cases, the true risk was thought to be about half this estimate [2] . More recently, the SSPE risk was estimated at approximately 1:5560 in England and Wales for children infected before age 1 year [5] and as high as 1:1700 in Germany for children infected before age 5 years [6] .
Although endemic measles transmission has been eliminated in North and South America and Australia, measles is still endemic in much of the world [7] . Therefore, US cases and outbreaks continue to occur related to international travel. A recent outbreak associated with a California theme park infected >125 people [8] .
We describe the epidemiology and risk factors associated with SSPE cases diagnosed in California during 1998-2015 and identified by the California Department of Public Health (CDPH).
METHODS
Cases meeting the Centers for Disease Control and Prevention (CDC) SSPE definition were included. These cases had a clinically compatible illness with either elevated measles antibody detection in cerebrospinal fluid (CSF) or typical histologic findings in brain biopsy [9] . Persons hospitalized with a clinically compatible illness and medical record documentation of SSPErelated complications were also included.
Cases were identified by 3 methods: (1) testing performed by the CDPH Encephalitis Project for patients with unexplained neurologic illness; (2) review of 1998-2014 California death certificate data for SSPE reported as a cause of death; and (3) notification by CDC of patients with brain biopsies in which measles RNA or antigen was detected. All cases were verified by medical record review.
Available CSF and serum samples were evaluated for immunoglobulin G (IgG) antibodies to measles virus. IgG detection was performed using an in-house indirect enzyme immunoassay at the CDPH Viral and Rickettsial Disease Laboratory (VRDL) [10] or by immunofluorescence assay at clinical laboratories. A subset of cases was also tested for IgG antibodies to herpes simplex virus to assess integrity of the blood-brain barrier [11] .
RESULTS

Demographics
Nineteen possible SSPE cases were identified; 11 (58%) through physician requests for testing of patients with undiagnosed neurologic disease, 7 (37%) through death certificate review, and 1 (5%) reported by CDC. Two cases whose death certificates included SSPE as a cause of death, but for whom SSPE could not be verified via medical records, were excluded from further analysis. Five cases have previously been reported [11] ; 2 cases were published as case reports [12, 13] .
Seventeen cases of SSPE met the case definition and were included. Cases were born between 1976 and 2011. Males (n = 12) outnumbered females 2.4:1. Seven (41%) cases were Asian/Pacific Islander, 6 (35%) Hispanic, and 4 (24%) were White non-Hispanic. Eight (47%) were born in the United States, and 8 (47%) were born abroad ( Table 1) . Country of birth was unknown for 1 case.
Measles History
Twelve (71%) cases had a history of measles infection or a compatible febrile rash illness prior to SSPE diagnosis. Of the remaining 5 cases, 3 (18%) had no history of previous febrile rash illness, and measles history was unknown for 2 (12%) cases.
All 12 cases with a history of febrile rash illness were ill prior to age 15 months. Five (42%) cases were infected at age 6 months or younger, and an additional 6 (50%) cases were infected before age 12 months. One (8%) case had reported infection at age 14 months.
Of these 12 cases, 8 (67%) were residents of California at the time of infection, 7 of whom were thought to have been infected in California. Two cases were reportedly exposed to measles during known outbreaks in California. Four cases were presumed exposed to measles in California because they were born in California, lived in California at the time of SSPE diagnosis, and had no reported international travel prior to measles diagnosis. One case was born outside the United States, but immigrated to California several months prior to being hospitalized for measles in California. The final case (eighth California resident) had traveled to Germany immediately preceding measles infection (Figure 1) , and was found to be infected with a measles genotype (D4) circulating in Europe at the time of exposure. Of note, a ninth case with no history of febrile rash illness was born in the United States in 1989 and had no international travel prior to SSPE diagnosis, suggesting measles exposure and infection in the United States, although age at the time of infection is unknown.
Of the 4 cases who were known not to be infected in the United States, 3 (25%) were infected while living in their country of birth outside the United States (Table 1) ; measles is endemic in all of these countries. Genotyping was performed on a case thought to have been exposed in India and the genotype (D7) was compatible with strains likely circulating in India at that time. The country of birth and location of measles exposure was unknown for 1 (8%) case.
All 7 cases exposed in California were likely exposed during a measles resurgence between 1988 and 1991 ( Figure 1 ) when 9564 measles cases were reported in children <5 years of age in California (unpublished surveillance data); 7 SSPE cases were infected in California before age 5 years during this time, resulting in an SSPE case rate of 1:1367 for children infected with measles before age 5 years. Six of the 7 (86%) Californiaacquired SSPE cases occurred in children who had measles infection prior to age 12 months. Between 1988 and 1991, 3651 cases of measles among children <12 months of age were reported in California (unpublished surveillance data), resulting in an SSPE case rate of 1:609 for children infected with measles prior to age 12 months. Of these 7 cases, 3 (43%) were Hispanic, and 2 (28.5%) each were Asian/Pacific Islander and white non-Hispanic.
There was no evidence that any case received measles vaccination prior to measles infection. Of the 12 cases with a history of a febrile rash illness, none of 6 (50%) cases with documented vaccination status at time of infection had received measles vaccine prior to infection. Among the 6 cases with undocumented measles vaccination status at time of infection, 2 (29%) were age 6 months or younger when infected with measles and were too young to have been vaccinated prior to infection. Three (43%) were infected with measles prior to age 12 months and were unlikely to have been vaccinated. Two lived in countries (United States and Mexico) that recommend routinely administering measles-containing vaccine no earlier than 1 year of age (although vaccine can be administered to infants aged 6-11 months if international travel is planned), and the third case lived in the Philippines and was infected with measles at age 8 months, before that country's routine vaccination age of 9 months. Finally, one US-born child had undocumented vaccination status at the time of measles infection at 14 months, which was within the routine timeframe for first measles vaccination (12-15 months); however, some pediatric practices routinely administer the first dose of measles-containing vaccine at 15 months (Table 2) . Of the 5 (29%) cases with no history of measles infection, 2 (40%) had unknown immunization status at the time of SSPE diagnosis and 2 (40%) were unimmunized. One case (20%) was unlikely to have received measles-containing vaccine, as only 2 unknown type vaccinations prior to age 9 years were reported.
SSPE Diagnosis
The median age at presentation was 12 years (range, 3-35 years). The latency period between measles infection and SSPE diagnosis was known for 12 cases; the median was 9.5 years (range, 2.5-34 years). All cases presented to care because of the abrupt onset of new neurologic symptoms. However, the majority of cases also had long-standing cognitive or motor problems that could have represented early SSPE symptoms (Table 1) . One patient presented with symptoms during the third trimester of her pregnancy. Early in the course of SSPE, most cases (11 [65%]) had abnormal motor symptoms including jerking movements, seizures, tremors, poor coordination, ataxia, or weakness. Nine (53%) had behavior problems including inattention, hyperactivity, lethargy, language problems, poor school performance, forgetfulness, or staring spells. Ultimately, all cases developed cognitive and motor decline. Eleven (65%) had myoclonic jerks at some point in their disease course. Ten (59%) cases are deceased, 1 (6%) case born in 2011 is alive at this time, and 6 (35%) were lost to follow-up.
Fifteen cases had measles virus IgG antibodies detected in CSF ( Table 2 ). Both cases without available measles antibody results had compatible histories and were reported as confirmed SSPE cases per their medical records. Enzyme immunoassay tests performed at CDPH VRDL on 10 cases were positive for measles virus IgG in both serum and CSF. To demonstrate that the measles virus-specific IgG detected in CSF was likely due to intrathecal antibody production, concurrent testing for herpes simplex virus (HSV) IgG antibodies was performed on 7 of these 10 cases. HSV IgG results were positive in serum but negative in CSF, suggesting that the positive CSF measles virus IgG findings were due to intrathecal antibody production. Five of the 15 cases were measles virus IgG positive in CSF by immunofluorescence assay at clinical laboratories. Two cases underwent genotyping at CDC; one was genotype D4, the other D7 (Table 2) .
CSF profiles at the time of SSPE diagnosis were available for 12 cases; all were relatively normal ( Table 2) . EEG reports were available for 16 cases; all were abnormal. Magnetic resonance imaging reports were obtained for 13 cases and ranged from normal to severe generalized atrophy (Table 2 ).
DISCUSSION
Measles virus continues to circulate in much of the world [14] , and this case series highlights the importance of measles prevention. Measles vaccination reduces the risk of measles infection and SSPE [2] . Because infants infected with measles are at highest risk for SSPE, it is important that they are protected against measles by vaccination and herd immunity [4] . Although the first dose of measles, mumps, and rubella (MMR) vaccine is routinely recommended at age 12-15 months in the United States, CDC recommends that infants aged 6-11 months receive 1 dose of MMR vaccine, and children aged ≥12 months receive 2 doses prior to international travel [7] . Because 5%-7% of individuals are not protected after 1 dose, parents might choose to avoid endemic areas until their child has received 2 doses of vaccine; a second dose can be given as early as 4 weeks after the first dose.
In our case series, all cases with known measles onset dates were infected before 12-15 months of age, when most US-born children are not yet vaccinated. Some children were born in measles-endemic countries and were likely infected with measles before moving to the United States. Because there are currently more cases of measles outside the United States than within, it is more likely that US-born children will be exposed to measles during international travel. However, recently 20 unimmunized infants 15 months of age or younger were infected during a measles outbreak associated with a California theme park (unpublished surveillance data) [8] . Because measles can be introduced into the United States at any time, reducing the risk of measles and subsequent SSPE for US infants requires sustaining high levels of immunization domestically while continuing efforts to eliminate the disease where it is still endemic. As long as measles continues to circulate in the world, measles infection can occur in unvaccinated infants who have an elevated risk of SSPE.
SSPE diagnosis is often not made because of the prolonged period between measles infection and the onset of neurological symptoms. Several of our cases had no known history of a febrile rash illness, although the SSPE diagnosis indicates that a subclinical or undiagnosed infection occurred [2] ; subclinical disease might be more common in young infants [15] . Two of our cases had particularly long latency periods (>25 years). One patient with history of cerebral palsy, seizures, and developmental delay since childhood was not evaluated for SSPE until age 35, when a tremor and notable decline in mental status occurred over a period of a few weeks to months. The second patient was previously healthy with possible preceding "mental slowness" and was evaluated for SSPE at age 29 after developing lower limb weakness during the third trimester of pregnancy. Initial evaluation showed rigidity, hyperreflexia, and positive Babinski sign, and a subsequent rapid decline in mental status. SSPE diagnosis during pregnancy has been reported in the literature, suggesting that the altered immune system during pregnancy might permit the virus, if present, to replicate in the central nervous system [13, 16] .
SSPE cases can also be missed because measles history is often not obtained unless SSPE is specifically considered as part of the differential diagnosis. If no known measles infection occurred, or if the child was vaccinated, SSPE might not be considered or quickly disregarded. One case of SSPE was diagnosed in a young child who was hospitalized with a mild febrile rash illness with cough and coryza in infancy, but who had not been suspected to have measles. To correctly diagnose SSPE, clinicians must maintain a high level of suspicion based on the patient's clinical presentation and the likelihood of exposure to measles. Once considered, SSPE is generally a simple diagnosis to make, requiring only CSF antibody testing that can be performed in public health and clinical laboratories [11] .
All SSPE cases exposed to measles in the United States were exposed in California during a measles resurgence between 1988 and 1991. During this time, >55 000 cases of measles were reported in the United States, including >18 000 cases in California (unpublished surveillance data) [17, 18] . Children <5 years of age had the highest incidence of measles during this time period, particularly unvaccinated racial and ethnic minority children, and complications occurred in 20.5% of cases at the time of infection [18, 19] . Our SSPE case rate of 1:1367 for children <5 years of age at the time of measles infection during 1988-1991 is similar to the recent report from Germany [6] . More importantly, 6 (86%) of the 7 SSPE cases who were exposed in California had measles infection when they were <12 months of age, resulting in a case rate of 1:609 for children who were infected with measles prior to age 12 months, which is the highest rate reported in the literature. However, these calculations could have been affected by underreporting of both measles and SSPE cases. A few articles attempted to quantify the degree of nonreporting during this time period. In New York, total reporting of measles cases to public health was estimated at 45% from 12 hospitals [20] . In Los Angeles, hospital-based measles reporting during 1989 was estimated to be 51% [21] . Reporting was less sensitive (29%) based on parents' self-reported recall of a child's unverified measles illness, but was consistent with the previous studies (48%-63%) among children with a measles diagnosis or medical record documentation of compatible symptoms and/or with an epidemiologic link to another case [22] . Overall, measles reporting improved during the epidemic [22] . Because measles reporting relies on clinical suspicion, physician recognition of illness is more likely when outbreaks are well publicized, as occurred during this epidemic [23] . Using the 1989 Los Angeles reporting rate of about 50%, a conservative estimate brings our rates of SSPE closer to 1:2700 for children infected before age 5 years, and 1:1200 for infants infected before age 1 year, which is still higher than has been previously published. However, this calculation does not take into account the underdiagnosis of SSPE, the nonreportable status of SSPE, nor cases that might have occurred in patients who left California prior to SSPE diagnosis. If the true number of SSPE cases is also larger, rates would be closer to our initial calculations. For example, a child born in 1989, whose family had no recollection of measles disease, who never left the country, but later developed SSPE was excluded from our rate calculations; the child was likely infected with measles during infancy at the height of the outbreak in California.
This case series has several limitations. SSPE cases were identified primarily though physician requests for testing of patients with neurological disease of unknown etiology; in most cases SSPE was not suspected. Cases were also identified through death certificate review. These methods, while specific for SSPE identification, are likely to underestimate the actual number of SSPE cases. Medical records were not available for all cases, particularly less recent cases, so some identified SSPE cases had to be excluded from further analysis. Neither cases nor their families were interviewed for this series, and thus clinical history was based on medical record review. Additionally, antibody titer results from clinical laboratories were reported, but specific testing parameters are unknown.
SSPE is a devastating condition that is more common among children infected with measles at a young age than has been previously estimated. All SSPE cases in California during the past 2 decades occurred among persons who had measles infection before the age of 15 months. Avoidance of travel to endemic areas can reduce but not eliminate risk, particularly for infants <6 months of age. Older infants and children should receive early doses of MMR vaccine prior to international travel. Clinicians should be aware of the possibility of SSPE as a diagnosis even in adult patients or patients without specific history of measles infection. Finally, this case series demonstrates the potentially high human cost of "natural" measles immunity. 
